Case Reports
doi: 10.1007/BF00866925.
Clonidine in the treatment of spasticity in patients with multiple sclerosis
- PMID: 8568536
- DOI: 10.1007/BF00866925
Item in Clipboard
Case Reports
Clonidine in the treatment of spasticity in patients with multiple sclerosis
J Neurol.
1995 Oct.
No abstract available
Similar articles
-
Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.Acta Neurol Scand. 1988 Mar;77(3):224-30. doi: 10.1111/j.1600-0404.1988.tb05899.x. Acta Neurol Scand. 1988. PMID: 3376747
-
Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis.Can J Neurol Sci. 1989 Nov;16(4):451. doi: 10.1017/s0317167100029577. Can J Neurol Sci. 1989. PMID: 2804809 No abstract available.
-
[Long-term treatment of spasticity with tisanidine (sirdulad) in 2 cases of multiple sclerosis].Wiad Lek. 1987 Dec 15;40(24):1711-4. Wiad Lek. 1987. PMID: 3451608 Polish. No abstract available.
-
[Pharmacological treatment of spasticity in multiple sclerosis].Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8. Rev Neurol (Paris). 2012. PMID: 22721367 Review. French.
-
An approach to switching patients from baclofen to tizanidine.Hosp Med. 1998 Oct;59(10):778-82. Hosp Med. 1998. PMID: 9850294 Review.
Cited by
-
Anti-spasticity agents for multiple sclerosis.Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical